首页> 美国卫生研究院文献>International Journal of Hematology-Oncology and Stem Cell Research >Late Complications in acute Leukemia patients following HSCT: A single center experience
【2h】

Late Complications in acute Leukemia patients following HSCT: A single center experience

机译:HSCT后急性白血病患者的晚期并发症:单中心经验

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

>Background: Hematopoietic stem cell transplantation (HSCT) is currently the only curative treatment for acute leukemia. As HSCT improves the long-term survival, it is necessary to assess the late-onset complications affecting the quality of life following HSCT. >Subjects and Methods: The study included 122 patients (65 male, 57 female) with leukemia (72 AML and 50 ALL) who received transplants from fully- matched siblings, unrelated donors and unrelated cord blood donors between February 2013 and August 2014 in Shariati Hospital. All study participants were over 18 years of age and had the minimum and maximum survival of 2 and 5 years, respectively. Patients who received HLA-haploidentical SCT were excluded from the study. All allogeneic recipients received busulfan and cyclophosphamide as conditioning regimen. Nobody received TBI-based conditioning regimen in this study. Patients were evaluated for cardiovascular, vision, psychological, endocrine, fertility problems and secondary malignancies one year after transplantation. >Results >: Data were analyzed using SPSS 15.0. Mitral and tricuspid regurgitation (TR/MR) were the most common cardiac complications (n=12, 10.5%).Thirty-nine percent of patients had psychological problems, especially depression (34%). Cataract was observed in 13% of patients and 34% complained of dry eye. Symptomatic pulmonary changes were found in 13 patients (10.6%). None of the HSCT survivors had experienced fertility before study entry. According to LH and FSH levels, 15% and 9% of females had ovarian failure, respectively. Testosterone level was less than normal in 49(84%) men and, according to their FSH and LH level, 20 (41%) had secondary hypogonadism and 29 (59%) had primary gonadal dysfunction. >Conclusion: The results showed that patients who received Bu/Cy conditioning regimen experienced fewer late side effects such as cataract formation and hypothyroidism, compared to previous studies using TBI-based conditioning regimen.
机译:>背景:造血干细胞移植(HSCT)是目前治疗急性白血病的唯一方法。由于HSCT可提高长期生存率,因此有必要评估影响HSCT后生活质量的晚期并发症。 >受试者和方法:该研究包括122例白血病(72例AML和50例ALL)的白血病患者(男65例,女57例),他们在2月之间接受了完全匹配的兄弟姐妹,无关亲戚和无关脐血献血者的移植2013年和2014年8月在Shariati医院。所有研究参与者均超过18岁,分别具有2年和5年的最小和最大生存期。接受HLA单倍性SCT的患者被排除在研究之外。所有异基因接受者均接受白消安和环磷酰胺作为调理方案。在这项研究中,没有人接受基于TBI的调理方案。移植一年后评估患者的心血管,视力,心理,内分泌,生育问题和继发性恶性肿瘤。 >结果 >:使用SPSS 15.0分析数据。二尖瓣和三尖瓣关闭不全(TR / MR)是最常见的心脏并发症(n = 12,10.5%)。39%的患者有心理问题,尤其是抑郁症(34%)。在13%的患者中观察到白内障,其中34%的患者患有干眼症。有症状的肺部改变发现13例(10.6%)。 HSCT幸存者在进入研究之前均未经历过生育。根据LH和FSH的水平,分别有15%和9%的女性患有卵巢衰竭。男性的睾丸激素水平低于正常水平(84%),根据他们的FSH和LH水平,有20例(41%)患有继发性腺功能减退,而29例(59%)患有原发性腺功能低下。 >结论:结果表明,与以前使用基于TBI的调理方案相比,接受Bu / Cy调理方案的患者较少出现后期副作用,例如白内障形成和甲状腺功能减退。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号